Access to Multidisciplinary Care in Early Diabetes: A Study of Medicare-Funded Services
April 17, 2026
Brand Name :
Synonyms :
Class :
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
when both the drugs are combined, the risk or severity of adverse effects increases